• Title/Summary/Keyword: Radiation Measure

Search Result 809, Processing Time 0.026 seconds

Radiation Dose and Image Evaluation for Position Change in Low Extremity Teleography (하지전신계측검사에서 자세의 변화에 따른 방사선량 및 영상평가)

  • Kim, Yeongcheon;Song, Jongnam;Choi, Namgil;Jeong, Yeon;Han, Jaebok
    • Journal of the Korean Society of Radiology
    • /
    • v.8 no.7
    • /
    • pp.409-415
    • /
    • 2014
  • In this study, radiation doses of major organs in various postures in lower extremity teleography were measured and compared to investigate the utility of the test methods. Ten adult males who underwent lower extremity teleography at a tube voltage of 73 kVp, tube current of 32 mAs, and SID of 180 cm. Using rando phantom, glass dosimeter was attached to the eye lens, thyroid gland, and genital gland to measure the radiation dose in each area 5 times in each anteroposterior posture and posteroanterior posture. The results were compared and analyzed through Paired T-test. The images from the anteroposterior posture and posteroanterior posture were evaluated through the blind test on a scale of 5. As a result, the posteroanterior method could reduce the dose than the anteroposterior posture method: less dose for the eye lens by 6%, thyroid gland by 6%, and genital gland by 26%. Since there was no significant difference in image evaluation, the posteroanterior posture is considered better than the anteroposterior posture in lower extremity teleography.

IN-VIVO DOSE RECONSTRUCT10N USING A TRANSMISION FACTOR AND AN EFFECTIVE FIELD CONCEPT (팬텀투과계수와 유효조사면 개념을 이용한 종양선량 확인에 관한 연구)

  • Kim, You-Hyun;Yeo, In-Hwan;Kwon, Soo-Il
    • Journal of radiological science and technology
    • /
    • v.25 no.1
    • /
    • pp.63-71
    • /
    • 2002
  • The aim of this study Is to develop a simple and fast method which computes in-vivo doses from transmission doses measured doting patient treatment using an ionization chamber. Energy fluence and the dose that reach the chamber positioned behind the patient is modified by three factors: patient attenuation, inverse square attenuation. and scattering. We adopted a straightforward empirical approach using a phantom transmission factor (PTF) which accounts for the contribution from all three factors. It was done as follows. First of all, the phantom transmission factor was measured as a simple ratio of the chamber reading measured with and without a homogeneous phantom in the radiation beam according to various field sizes($r_p$), phantom to chamber distance($d_g$) and phantom thickness($T_p$). Secondly, we used the concept of effective field to the cases with inhomogeneous phantom (patients) and irregular fields. The effective field size is calculated by finding the field size that produces the same value of PTF to that for the irregular field and/or inhomogeneous phantom. The hypothesis is that the presence of inhomogeneity and irregular field can be accommodated to a certain extent by altering the field size. Thirdly, the center dose at the prescription depth can be computed using the new TMR($r_{p,eff}$) and Sp($r_{p,eff}$) from the effective field size. After that, when TMR(d, $r_{p,eff}$) and SP($r_{p,eff}$) are acquired. the tumor dose is as follows. $$D_{center}=D_t/PTF(d_g,\;T_p){\times}(\frac{SCD}{SAD})^2{\times}BSF(r_o){\times}S_p(r_{p,eff}){\times}TMR(d,\;r_{p,eff})$$ To make certain the accuracy of this method, we checked the accuracy for the following four cases; in cases of regular or irregular field size, inhomogeneous material included, any errors made and clinical situation. The errors were within 2.3% for regular field size, 3.0% irregular field size, 2.4% when inhomogeneous material was included in the phantom, 3.8% for 6 MV when the error was made purposely, 4.7% for 10 MV and 1.8% for the measurement of a patient in clinic. It is considered that this methode can make the quality control for dose at the time of radiation therapy because it is non-invasive that makes possible to measure the doses whenever a patient is given a therapy as well as eliminates the problem for entrance or exit dose measurement.

  • PDF

Measurement of Skin Dose for Rectal Cancer Patients in Radiotherapy using Optically Stimulated Luminescence Detectors (OSLDs) (광자극발광선량계(OLSDs)를 이용한 직장암 방사선치료 환자의 피부선량 측정)

  • Im, In-Chul;Yu, Yun-Sik;Lee, Jae-Seung
    • Journal of Radiation Protection and Research
    • /
    • v.36 no.2
    • /
    • pp.86-92
    • /
    • 2011
  • This study used the optically stimulated luminescence dosimeters (OSLDs), recently, received the revaluation of usefulness in vivo dosimetry, and the diode detecters to measure the skin dose of patient with the rectal cancer. The measurements of dose delivered were compared with the planned dose from the treatment planning system (TPS). We evaluated the clinical application of OSDs in radiotherapy. We measured the calibration factor of OSLDs and used the percent depth dose to verified, also, we created the three point of surface by ten patients of rectal cancer to measured. The calibration factors of OSLD was 1.17 for 6 MV X-ray and 1.28 for 10 MV X-ray, demonstrating the energy dependency of X-ray beams. Comparison of surface dose measurement using the OSLDs and diode detectors with the planned dose from the TPS, The skin dose of patient was increased 1.16 ~ 2.83% for diode detectors, 1.36 ~ 2.17% for OSLDs. Especially, the difference between planned dose and the delivery dose was increased in the perineum, a skin of intense flexure region, and the OSLDs as a result of close spacing of measuring a variate showed a steady dose verification than the diode detecters. Therefore, on behalf of the ionization chamber and diode detecters, OSLDs could be applied clinically in the verification of radiation dose error and in vivo dosimety. The research on the dose verification of the rectal cancer in the around perineal, a surface of intense flexure region, suggest continue to be.

A Research on Superparamagnetic Iron Oxide Nanoparticles' Toxicity to U373MG Cell and its Effect on the Radiation Survival Curve (산화철 나노입자의 U373MG 세포 독성평가 및 방사선 세포생존 곡선에 미치는 영향에 대한 연구)

  • Kang, Seonghee;Kim, Jeonghwan;Kim, Dokyung;Kang, Bosun
    • Journal of the Korean Society of Radiology
    • /
    • v.6 no.6
    • /
    • pp.507-513
    • /
    • 2012
  • This research was performed to evaluate the superparamagnetic iron oxide nanoparticles'(SPIONs) cell toxicity and to measure the radiation cell survival curve changes of SPIONs-uptake glioblastoma multiforme cells. The results could be practically used as the fundamental data to ameliorate proton beam cancer therapy, for example, providing necessary GBM treatment dose in the proton beam therapy when the therapy takes advantage of SPIONs. The assessment of the toxicological evaluation of synthesized SPIONs was accomplished by MTT assay as an in vitro experiment. The results showed no meaningful differences in the cell survival rate at the $1-100{\mu}g/ml$ SPIONs concentrations, but the cell toxicity was shown as the cell survival rate decreased up to 74.2% at the $200{\mu}g/ml$ SPIONs concentration. Then, we measured each radiation cell survival curve for U373MG cells and SPIONs-uptake U373MG cells with 0~5 Gy of proton beam irradiations. It is learned from the analysis of the experimental results that the SPION-uptake cells' radiation survival rate was more rapidly decreased as the irradiation dose increased. In conclusion we confirmed that SPIONs-uptake in U373MG cells induces cell death at the much less dose than the lethal dose of SPION-non-uptake cell. This research shows that the therapeutic efficacy of glioblastoma multiforme treatment in proton beam therapy can be improved by SPIONs targeting to the GBM cells.

The Effect of Thin Teflon on TLD Response for in vivo Dosimetry of Radiotherapy (생체 내 흡수선량 측정을 위한, 얇은 테프론의 TLD 반응감도에 대한 효과성)

  • Kim, Sookil;Yum, Ha-Young;Jeong, Tae-Sig;Moon, Chang-Woo
    • Progress in Medical Physics
    • /
    • v.14 no.2
    • /
    • pp.74-80
    • /
    • 2003
  • The purpose of this study was to evaluate the performance of the teflon encapsulated TLD rod, which may be used in nuclear medicine for the direct in vivo measurements of radiation dose. We analyzed the influence of teflon encapsulation for measuring absorbed dose. An experiment was carried out to evaluate and observe the response of a LiF TLD-100 rod in a thin-wall teflon capsule at different depths in a solid phantom. An adult anthropomorphic phantom was used to measure the absorbed dose using thin teflon encapsulated TLD. The measurements of PDD-, and TMR in solid phantom and athe bsorbed dose in humanoid phantom performed with normal TLD were compared with values obtained by teflon encapsulated TLD. It was demonstrated that the difference of TL response of LiF in phantom with and without teflon thin-wall capsule was less than 3% under the same conditions beyond the build-up region. However, significant differences were observed near the phantom surface because of the build-up effect caused by the thin-wall thickness of the teflon capsule. Thus, our study showed that the contribution of teflon thin-wall capsule to TLD response for the megavoltage photon beams was negligible and that it did not significantly effect dose measurement. The teflon encapsulated TLD described in this work has been proven to be appropriate for in vivo dosimetry in therapeutic environments.

  • PDF

Development of Enhanced DAP(Dose Area Product) (성능이 향상된 면적선량계(DAP) 개발)

  • Lee, Young-Ji;Lee, Sang-Heon;Lee, Seung-Ho
    • Journal of IKEEE
    • /
    • v.23 no.2
    • /
    • pp.739-742
    • /
    • 2019
  • In this paper, we propose enhanced DAP(Dose Area Product). The development of enhanced DAP proposed in this paper has optimized the area dose meter that was developed previously. The development of enhanced DAP performed Optimized design of charge integrator and ADC circuit, optimization of line transceiver for RS-485 communication, optimization of display circuit, and optimization of PC-based control program for interlocking and aging. As a result of evaluating the performance of the proposed system in an accredited testing laboratory, Radiation dose dependence and Radiation quality dependence were measured to be 4.2%, which is below ${\pm}15%$ of international standard. Energy range/Tube voltage was confirmed in the range of 30~150kV. The sensitivity difference between sensor field and sensor field area dose sensitivity was measured to be 4.3%, and it was confirmed that it operates normally under ${\pm}15%$ of international standard. In order to measure the reproducibility of the area dosimeter, it was confirmed that it was 0% and it was operated normally at less than 2% of IEC60580 recommendation. Digital resolution was confirmed to be a minimum unit of $0.01{\mu}Gy{\cdot}m^2$ within the error range for the reference dose per hour.

Development and Feasibility Evaluation of CsPbBr3 Dosimeter for Brachytherapy (근접방사선치료용 CsPbBr3 선량계 제작 및 적용가능성 평가)

  • Yang, Seung-Woo;Park, Sung-Kwang
    • Journal of the Korean Society of Radiology
    • /
    • v.16 no.4
    • /
    • pp.405-410
    • /
    • 2022
  • In brachytherapy, a radiation source is inserted into the body to kill tumor tissue. Therefore, it is important to accurately measure the location of the source and the dose distribution. In this study, a dosimeter that can be used for brachytherapy was developed using CsPbBr3 which is cheaper than the existing detector materials and has a simpler manufacturing process. The CsPbBr3 dosimeter performance was evaluated by analyzing reproducibility, linearity, and distance dependence in 192Ir source. As a result of reproducibility evaluation, the RSD was 1.36%, which satisfies the standard value of 1.5%. As a result of the linearity evaluation, the R2 value was 0.9993, which satisfies the standard R2 of 0.9990. The distance dependence evaluation showed a signal value that decreased exponentially as the distance increased. The evaluation results show that the CsPbBr3 dosimeter satisfies the evaluation criteria and can be used as a brachytherapy quality assurance dosimeter.

A Study on the Secondary Carcinogenesis Rate of Vestibular Schwannoma Disease using Glass Dosimeter (유리선량계를 이용한 청신경초종 질환의 2차 발암률에 관한 연구)

  • Joo-Ah Lee;Gi-Hong Kim
    • Journal of the Korean Society of Radiology
    • /
    • v.17 no.2
    • /
    • pp.243-248
    • /
    • 2023
  • This study aims to analyze the secondary carcinogenesis rate caused by exposure of organs at risk of damage using a glass dosimeter during radiosurgery in vestibular schwannoma disease. Using a pediatric phantom of human tissue equivalent material, the volume of the tumor was set to a total of three volumes: 0.506 cm3, 1.008 cm3, and 2.032 cm3, and a radiosurgery plan was established with an average dose of 18.4 ± 3.4 Gy. After mounting the human body phantom on the table of surgical equipment, glass dosimeters were placed on the right eye, left eye, thyroid gland, thymus, right lung, and left lung to measure the exposure dose, respectively. In this study, the incidence of secondary cancer due to exposure to damaged organs during gamma knife radiosurgery in vestibular schwannoma disease with the largest tumor volume of 2.032 cm3 was measured with a glass dosimeter. This study studies the risk of secondary radiation exposure dose that can occur during stereotactic radiosurgery, and it is considered that it will be used as basic data in the field of radiation damage related to the stochastic effect of radiation in the future.

A Study on the Patient Exposure Doses from the Panoramic Radiography using Dentistry (치과 파노라마 촬영에서 환자의 피폭선량에 관한 연구)

  • Park, Ilwoo;Jeung, Wonkyo;Hwang, Hyungsuk;Lim, Sunghwan;Lee, Daenam;Im, Inchul;Lee, Jaeseung;Park, Hyonghu;Kwak, Byungjoon;Yu, Yunsik
    • Journal of the Korean Society of Radiology
    • /
    • v.7 no.1
    • /
    • pp.17-24
    • /
    • 2013
  • This study estimate radiation biological danger factor by measuring patient's exposed dose and propose the low way of patient's exposed dose in panoramic radiography. We seek correcting constant of OSL dosimeter for minimize the error of exposed dose's measurement and measure the Left, Right crystalline lens, thyroid, directly included upper, lower lips, the maxillary bone and the center of photographing that indirect included in panoramic radiography by using the human body model standard phantom advised in ICRP. In result, the center of photographing's level of radiation maximum value is $413.67{\pm}6.53{\mu}Gy$ and each upper, lower lips is $217.80{\pm}2.98{\mu}Gy$, $215.33{\pm}2.61{\mu}Gy$. Also in panoramic radiography, indirect included Left, Right crystalline lens's level of radiation are $30.73{\pm}2.34{\mu}Gy$, $31.87{\pm}2.50{\mu}Gy$, and thyroid's level of measured exposed dose can cause effect of radiation biological and we need justifiable analysis about radiation defense rule and substantiation advised international organization for the low way of patient's exposed dose in panoramic radiography of dental clinic and we judge need the additional study about radiation defense organization for protect the systematize protocol's finance and around internal organs for minimize until accepted by many people that is technological, economical and social fact by using panoramic measurement.

Verification of skin dose according to the location of tumor in Tomotherapy (토모테라피 시 종양의 위치에 따른 피부선량 검증)

  • Yoon, Bo Reum;Park, Su Yeon;Park, Byoung Suk;Kim, Jong Sik;Song, Ki Won
    • The Journal of Korean Society for Radiation Therapy
    • /
    • v.26 no.2
    • /
    • pp.273-280
    • /
    • 2014
  • Purpose : To verify the skin dose in Tomotherapy-based radiation treatment according to the change in tumor locations, skin dose was measured by using Gafchromic EBT3 film and compared with the planned doses to find out the gap between them. Materials and Methods : In this study, to measure the skin dose, I'm RT Phantom(IBA Dosimetry, Germany) was utilized. After obtaining the 2.5mm CT images, tumor locations and skin dose measuring points were set by using Pinnacle(ver 9.2, Philips Medical System, USA). The tumor location was decided to be 5mm and 10mm away from surface of the phantom and center. Considering the attenuation of a Tomo-couch, we ensured a symmetric placement between the ceiling and floor directions of the phantom. The measuring point of skin doses was set to have 3mm and 5mm thickness from the surface. Measurement was done 3 times. By employing TomoHD(TomoHD treatment system, Tomotherapy Inc., Madison, Wisconsin, USA), we devised Tomotherapy plans, measured 3 times by inserting Gafchromic EBT3 film into the phantom and compared the measurement with the skin dose treatment plans. Results : The skin doses in the upper part of the phantom, when the tumor was located in the center, were found to be 7.53 cGy and 7.25 cGy in 5mm and 3mm respectively. If placed 5mm away from the skin in the ceiling direction, doses were 18.06 cGy and 16.89 cGy; if 10mm away, 20.37 cGy and 18.27 cGy, respectively. The skin doses in the lower part of the phantom, when the tumor was located in the center, recorded 8.82 cGy and 8.29 cGy in 5mm and 3mm, each; if located 5mm away from the lower part skin, 21.69 cGy and 19.78 cGy were respectively recorded; and if 10mm away, 20.48 cGy and 19.57 cGy were recorded. If the tumor was placed in the center, skin doses were found to increase by 3.2~17.1% whereas if the tumor is 5mm away from the ceiling part, the figure decreased to 2.8~9.0%. To the Tomo-couch direction, skin doses showed an average increase of 11% or over, compared to the planned treatment. Conclusion : This study found gaps between planned skin doses and actual doses in the Tomotherapy treatment planning. Especially to the Tomo-cocuh direction, skin doses were found to be larger than the planned doses. Thus, during the treatment of tumors near the Tomo-couch, doses will need to be more accurately calculated and more efforts to verify skin doses will be required as well.